Sugi Predict

Sugi Predict / Compounds / SCHEMBL807365

SCHEMBL807365

SCHEMBL807365

Nc1ccc2c(c1)C1(c3cc(N)ccc3-2)c2cc(N)ccc2-c2ccc(N)cc21

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 3/20 0.47
▸ LMNA P02545 5/20 0.43
▸ MAPT P10636 5/20 0.43
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ MEN1 O00255 4/20 0.43
▸ KMT2A Q03164 4/20 0.43
▸ KDM4E B2RXH2 2/20 0.43
▸ OPRK1 P41145 1/20 0.43
▸ CYP3A4 P08684 4/20 0.42
▸ TSHR P16473 3/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ RAB9A P51151 4/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ HPGD P15428 2/20 0.41
▸ POLB P06746 2/20 0.41
▸ GAA P10253 2/20 0.41
▸ GLA P06280 1/20 0.41
▸ TP53 P04637 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16384350 0.93 PDK2 (0.44) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL30041848 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL808149 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL29362874 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL29571766 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL15695611 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL196364 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL25632111 0.89 SMN1; SMN2 (0.61) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL14174132 0.87 SMN1; SMN2 (0.59) PDK2LMNAMAPTSMN1; SMN2MEN1
SCHEMBL12681944 0.87 ACHE (0.42) PDK2LMNAMAPTSMN1; SMN2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024119131-A1 CONFIGURABLE AMORPHOUS CHARGE TRANSPORTING MATERIAL FOR EFFICIENT AND STABLE PEROVSKITE SOLAR CELL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-06-06 — — WO claimed
US-9637611-B2 3D covalent molecular network nanocapsule and preparing method thereof GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-02 — — US claimed
EP-2984079-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES Power Oleds Limited (GB) 2016-02-17 — — EP claimed
US-20140312278-A1 3D COVALENT MOLECULAR NETWORK NANOCAPSULE AND PREPARING METHOD THEREOF GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-10-23 — — US claimed
WO-2014167286-A2 HETEROCYCLIC COMPOUNDS AND THEIR USE IN ELECTRO-OPTICAL OR OPTO-ELECTRONIC DEVICES POWER OLEDS LIMITED (GB) 2014-10-16 — — WO claimed
WO-2024119131-A1 CONFIGURABLE AMORPHOUS CHARGE TRANSPORTING MATERIAL FOR EFFICIENT AND STABLE PEROVSKITE SOLAR CELL THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2024-06-06 — — WO disclosed
EP-3630896-B1 ELECTRONIC AND OPTOELECTRONIC DEVICES HAVING ANISOTROPIC PROPERTIES AND METHOD FOR THEIR PRODUCTION INNOVATIONLAB GMBH (DE) 2023-11-29 — — EP disclosed
US-11329229-B2 Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices KAUNO TECHNOLOGIES UNIVERSITETAS (LT) 2022-05-10 — — US disclosed
US-20210376324-A1 BATTERY MATERIALS Sumitomo Chemicao Comical Company Limeted (JP) 2021-12-02 — — US disclosed
CN-110256645-B Spherical covalent organic framework material and preparation method and application thereof 南京邮电大学 2021-10-26 — — CN disclosed
EP-2616493-B1 POLYMERISATION METHOD UNIV COURT UNIV OF EDINBURGH (GB) 2020-07-01 — — EP disclosed
EP-2616493-B1 POLYMERISATION METHOD UNIV COURT UNIV OF EDINBURGH (GB) 2020-07-01 — — EP disclosed
US-20140312278-A1 3D COVALENT MOLECULAR NETWORK NANOCAPSULE AND PREPARING METHOD THEREOF GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-10-23 — — US disclosed
US-20140312278-A1 3D COVALENT MOLECULAR NETWORK NANOCAPSULE AND PREPARING METHOD THEREOF GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-10-23 — — US disclosed
WO-2014147134-A1 AZABENZIMIDAZOLE CARBENE COMPLEXES AS EFFICIENCY BOOSTER IN OLEDS BASF SE (DE) 2014-09-25 — — WO disclosed
US-20130267616-A1 Polymerisation Method UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2013-10-10 — — US disclosed
US-20130267616-A1 Polymerisation Method UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2013-10-10 — — US disclosed
US-20130267616-A1 Polymerisation Method UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2013-10-10 — — US disclosed
WO-2012170571-A1 HETEROLEPTIC IRIDIUM CARBENE COMPLEXES AND LIGHT EMITTING DEVICE USING THEM UNIVERSAL DISPLAY CORPORATION (US) 2012-12-13 — — WO disclosed
WO-2012035327-A1 POLYMERISATION METHOD UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED (GB) 2012-03-22 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329229-B2 Hole transporting organic molecules containing enamine groups for optoelectronic and photoelectrochemical devices OCIAD1, OCIAD2, SLCO4C1 PDK2 2297/4885LMNA 3695/4885MAPT 1504/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.